Javier Mar Medina-rekin lankidetzan egindako argitalpenak (7)

2022

  1. Development and Validation of a Discrete Event Simulation Model to Evaluate the Cardiovascular Impact of Population Policies for Obesity

    Medical Decision Making, Vol. 42, Núm. 2, pp. 241-254

2017

  1. Cost-effectiveness methods and newborn screening assessment

    Advances in Experimental Medicine and Biology (Springer New York LLC), pp. 267-281

2016

  1. Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

    Expert Opinion on Orphan Drugs, Vol. 4, Núm. 6, pp. 567-575

2015

  1. Coste-utilidad de asenapina frente a olanzapina para el tratamiento de los episodios maniacos de pacientes con trastorno bipolar tipo I

    Pharmacoeconomics - Spanish Research Articles, Vol. 12, Núm. 4, pp. 123-136

  2. Projecting Burden of Dementia in Spain, 2010-2050: Impact of Modifying Risk Factors

    Journal of Alzheimer's Disease, Vol. 48, Núm. 3, pp. 721-730

2014

  1. Cost-effectiveness of the use of biomarkers in cerebrospinal fluid for Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 42, Núm. 3, pp. 777-788

  2. Cost–Utility Analysis of Gastric Bypass for Severely Obese Patients in Spain

    Obesity Surgery, Vol. 24, Núm. 12, pp. 2061-2068